China growth and global non-US Internet equities

Blue Lotus Research Institute

Blue Lotus Research is a Hong Kong Type 4 Licensed investment advisory firm focusing on Chinese growth equities and global non-US Internet equities

[Meituan (3690 HK, BUY, TP HK$156) TP Change]: Counting on Execution to Navigate the Uncertainties

Despite Many Years and Efforts, Insurance Covered Online Pharmacies Still Only 0.8-3.6% of Total

The 3rd Plenum of CCPCC Announced An Courageous But Tough-To-Execute Communique

[Meituan (3690 HK, SELL, TP HK$70) TP Change]: Margin Reflects Persistent Competitive Pressure

[Meituan (3690 HK,BUY,TP HK$150) Rating Change]: A Turning Point Might Have Arrived on Two Catalysts

Meituan (3690 HK): Out of the Woods and Light a Fire

Andy Fu

Equity Bottom-Up

<ul>
<li>During the upcoming Dragon Boat Festival, both flight and railway traffic seems sluggish, indicating a cooled-down enthusiasm for long-distance trips due to budget constraints.</li>
<li>Data points to booming short-distance travel with self-driving as the major means, helped by lower price;</li>
<li>Benefiting from hotel booking and catering, Meituan is the biggest beneficiary of such consumption downgrade.</li>
</ul>


During the upcoming Dragon Boat Festival, both flight and railway traffic seems sluggish, indicating a cooled-down enthusiasm for long-distance trips due to budget constraints.
Data points to booming short-distance travel with self-driving as the major means, helped by lower price;
Benefiting from hotel booking and catering, Meituan is the biggest beneficiary of such consumption downgrade.


Meituan Is the Biggest Beneficiary of China's Domestic Travel Recovery